Stock Quote

Exchange: TSX
Symbol: CJB
Price $0.10
7/2/2009
2:43 PM ET
Minimum 20 minute delay

ConjuChem: The Next Generation in Medicines

ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Construct (DAC™) and Preformed Conjugate-Drug Affinity Construct (PC-DAC™). When applied to a given peptide, DAC™ and PC-DAC™ can create new drugs with similar therapeutic activities but with significantly longer durations of activity and improved safety profiles.

Webcasts

Event Company: ConjuChem Biotechnologies Inc.
Date & Time: December 4, 2008 at 8h30
Event URL: http://www.newswire.ca/en/webcast/viewEvent.cgi?
eventID=2499420

Press Releases

>> All press releases